Norvium Bioscience Drug Patent Portfolio
Norvium Bioscience owns 9 orange book drugs protected by 16 US patents with Accuneb having the least patent protection, holding only 1 patent. And Olux E with maximum patent protection, holding 4 patents. Given below is the list of Norvium Bioscience's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8460641 | Microemulsion process and composition | 05 Nov, 2028 | Active |
| US8962000 | Microemulsion and sub-micron emulsion process and compositions | 31 Aug, 2025 | Active |
| US7141237 | Pharmaceutical foam | 03 Feb, 2024 | Expired |
| US7374747 | Pharmaceutical foam | 23 Jan, 2024 | Expired |
| US6702997 | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma | 28 Dec, 2021 | Expired |
| US6632842 | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease | 28 Dec, 2021 | Expired |
| US6730288 | Mousse composition | 08 Sep, 2019 | Expired |
| US7029659 | Mousse composition | 08 Sep, 2019 | Expired |
| US7553835 | Topical antifungal composition | 19 Oct, 2018 | Expired |
| US8026238 | Topical antifungal composition | 19 Oct, 2018 | Expired |
| US5980867 | Flunisolide aerosol formulations | 06 Jul, 2018 | Expired |
| US7078058 | Corticosteroid-containing pharmaceutical composition | 24 May, 2017 | Expired |
| US6126920 | Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition | 01 Mar, 2016 | Expired |
| US5776433 | Flunisolide aerosol formulations | 07 Jul, 2015 | Expired |
| US5733569 | Galenic compositions comprising calcitonin and their use | 31 Mar, 2015 | Expired |
| US5759565 | Galenic compositions comprising calcitonin and their use | 31 Mar, 2015 | Expired |
Latest Legal Activities on Norvium Bioscience's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Norvium Bioscience.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 30 Oct, 2023 | US8026238 |
|
Maintenance Fee Reminder Mailed
Critical
| 15 May, 2023 | US8026238 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Sep, 2020 | US8460641 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 22 Oct, 2019 | US7374747 |
| File Marked Found | 03 Jul, 2019 | US6702997 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 20 Mar, 2019 | US8026238 |
| File Marked Found | 17 Oct, 2018 | US6632842 |
| File Marked Found | 02 Oct, 2018 | US6702997 |
|
Expire Patent
Critical
| 13 Aug, 2018 | US7078058 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 13 Apr, 2018 | US7141237 |
|
Maintenance Fee Reminder Mailed
Critical
| 26 Feb, 2018 | US7078058 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 14 Sep, 2017 | US7029659 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 14 Nov, 2016 | US8026238 |
|
Email Notification
Critical
| 14 Nov, 2016 | US8026238 |
|
Correspondence Address Change
Critical
| 10 Nov, 2016 | US8026238 |
Norvium Bioscience's Drug Patent Litigations
Norvium Bioscience's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on May 23, 1994, against patent number US5759565. The petitioner , challenged the validity of this patent, with AZRIA et al as the respondent. Click below to track the latest information on how companies are challenging Norvium Bioscience's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US5759565 | May, 1994 |
Decision
(25 Aug, 1997)
| AZRIA et al | |
Norvium Bioscience Drug Patents' Oppositions Filed in EPO
Norvium Bioscience drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on May 14, 2014, by Generics [Uk] Limited. This opposition was filed on patent number EP05775966A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
| | |||
| EP05775966A | May, 2014 | Henkel AG & Co. KGaA | Patent maintained as amended |
| EP05775966A | May, 2014 | Generics [UK] Limited | Patent maintained as amended |
Norvium Bioscience's Family Patents
Norvium Bioscience Drug List
Given below is the complete list of Norvium Bioscience's drugs and the patents protecting them.
1. Accuneb
Accuneb is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6702997 | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
28 Dec, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Accuneb's drug page
2. Aerospan Hfa
Aerospan Hfa is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5980867 | Flunisolide aerosol formulations |
06 Jul, 2018
(7 years ago)
| Expired |
| US5776433 | Flunisolide aerosol formulations |
07 Jul, 2015
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Aerospan Hfa's drug page
3. Duoneb
Duoneb is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6632842 | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
28 Dec, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Duoneb's drug page
4. Evoclin
Evoclin is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7141237 | Pharmaceutical foam |
03 Feb, 2024
(1 year, 5 months ago)
| Expired |
| US7374747 | Pharmaceutical foam |
23 Jan, 2024
(1 year, 5 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Evoclin's drug page
5. Extina
Extina is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7553835 | Topical antifungal composition |
19 Oct, 2018
(6 years ago)
| Expired |
| US8026238 | Topical antifungal composition |
19 Oct, 2018
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Extina's drug page
Explore Our Curated Drug Screens
6. Luxiq
Luxiq is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7078058 | Corticosteroid-containing pharmaceutical composition |
24 May, 2017
(8 years ago)
| Expired |
| US6126920 | Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition |
01 Mar, 2016
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Luxiq's drug page
7. Miacalcin
Miacalcin is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5733569 | Galenic compositions comprising calcitonin and their use |
31 Mar, 2015
(10 years ago)
| Expired |
| US5759565 | Galenic compositions comprising calcitonin and their use |
31 Mar, 2015
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Miacalcin's drug page
8. Olux
Olux is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6126920 | Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition |
01 Mar, 2016
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Olux's drug page
9. Olux E
Olux E is protected by 4 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8460641 | Microemulsion process and composition |
05 Nov, 2028
(3 years from now)
| Active |
| US8962000 | Microemulsion and sub-micron emulsion process and compositions |
31 Aug, 2025
(a month from now)
| Active |
| US6730288 | Mousse composition |
08 Sep, 2019
(5 years ago)
| Expired |
| US7029659 | Mousse composition |
08 Sep, 2019
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Olux E's drug page